Mirum Pharmaceuticals, Inc. (MIRM)
80.14
-2.25
(-2.73%)
USD |
NASDAQ |
Oct 16, 16:00
80.19
+0.05
(+0.06%)
After-Hours: 20:00
Mirum Pharmaceuticals Research and Development Expense (Annual) : 185.83M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 185.83M |
| December 31, 2024 | 140.10M |
| December 31, 2023 | 102.28M |
| December 31, 2022 | 106.50M |
| Date | Value |
|---|---|
| December 31, 2021 | 131.09M |
| December 31, 2020 | 81.30M |
| December 31, 2019 | 42.99M |
| December 31, 2018 | 2.331M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Incyte Corp. | 1.984B |
| Insmed, Inc. | 771.09M |
| Galectin Therapeutics, Inc. | 14.29M |
| Kodiak Sciences, Inc. | 182.37M |
| Praxis Precision Medicines, Inc. | 267.12M |